Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionextracellular matrix structural constituent

THSD4 PRG3 EFEMP1 MUC2 MUC4 MUC5AC

2.32e-05188616GO:0005201
GeneOntologyBiologicalProcesspositive regulation of mitophagy

HIF1A AMBRA1 NOD2

1.28e-0516603GO:1901526
GeneOntologyBiologicalProcesspositive regulation of autophagy of mitochondrion

HIF1A AMBRA1 NOD2

2.19e-0519603GO:1903599
GeneOntologyBiologicalProcessmaintenance of gastrointestinal epithelium

MUC2 MUC4 NOD2

4.53e-0524603GO:0030277
GeneOntologyCellularComponentmucus layer

MUC2 MUC5AC

2.35e-053592GO:0070701
DomainTIL_dom

LRP2 MUC2 MUC5AC

1.12e-0514603IPR002919
DomainVWD

MUC2 MUC4 MUC5AC

1.71e-0516603SM00216
DomainVWF_type-D

MUC2 MUC4 MUC5AC

1.71e-0516603IPR001846
DomainVWFD

MUC2 MUC4 MUC5AC

1.71e-0516603PS51233
DomainVWD

MUC2 MUC4 MUC5AC

1.71e-0516603PF00094
DomainCTCK_1

SLIT3 MUC2 MUC5AC

2.49e-0518603PS01185
DomainK_chnl_volt-dep_ERG

KCNH7 KCNH2

3.04e-053602IPR003967
DomainCT

SLIT3 MUC2 MUC5AC

4.65e-0522603SM00041
DomainG8

PKHD1 PKHD1L1

6.06e-054602PF10162
DomainG8_domain

PKHD1 PKHD1L1

6.06e-054602IPR019316
DomainG8

PKHD1 PKHD1L1

6.06e-054602PS51484
DomainG8

PKHD1 PKHD1L1

6.06e-054602SM01225
DomainPAS-assoc_C

HIF1A KCNH7 KCNH2

6.08e-0524603IPR000700
DomainCys_knot_C

SLIT3 MUC2 MUC5AC

6.89e-0525603IPR006207
DomainCTCK_2

SLIT3 MUC2 MUC5AC

6.89e-0525603PS01225
DomaincEGF

EFEMP1 LRP2 LRP1B

7.77e-0526603IPR026823
DomainPAC

HIF1A KCNH7 KCNH2

7.77e-0526603IPR001610
DomaincEGF

EFEMP1 LRP2 LRP1B

7.77e-0526603PF12662
DomainPAC

HIF1A KCNH7 KCNH2

7.77e-0526603SM00086
DomainPAC

HIF1A KCNH7 KCNH2

7.77e-0526603PS50113
DomainEGF_3

EFEMP1 SLIT3 LRP2 ADAM12 MUC4 LRP1B

1.06e-04235606PS50026
DomainEGF-like_dom

EFEMP1 SLIT3 LRP2 ADAM12 MUC4 LRP1B

1.45e-04249606IPR000742
DomainPAS

HIF1A KCNH7 KCNH2

1.46e-0432603SM00091
DomainPbH1

PKHD1 PKHD1L1

1.51e-046602SM00710
DomainWxxW_domain

MUC2 MUC5AC

1.51e-046602IPR025155
DomainMucin2_WxxW

MUC2 MUC5AC

1.51e-046602PF13330
DomainPbH1

PKHD1 PKHD1L1

1.51e-046602IPR006626
DomainEGF_1

EFEMP1 SLIT3 LRP2 ADAM12 MUC4 LRP1B

1.65e-04255606PS00022
DomainPAS

HIF1A KCNH7 KCNH2

1.76e-0434603IPR000014
DomainPAS

HIF1A KCNH7 KCNH2

1.76e-0434603PS50112
DomainEGF-like_CS

EFEMP1 SLIT3 LRP2 ADAM12 MUC4 LRP1B

1.87e-04261606IPR013032
DomainEGF_2

EFEMP1 SLIT3 LRP2 ADAM12 MUC4 LRP1B

2.03e-04265606PS01186
DomainEGF_Ca-bd_CS

EFEMP1 SLIT3 LRP2 LRP1B

2.67e-0497604IPR018097
DomainPectin_lyase_fold/virulence

PKHD1 PKHD1L1

2.81e-048602IPR011050
DomainEGF_CA

EFEMP1 SLIT3 LRP2 LRP1B

2.88e-0499604PS01187
DomainEGF-type_Asp/Asn_hydroxyl_site

EFEMP1 SLIT3 LRP2 LRP1B

3.74e-04106604IPR000152
DomainPAS_9

KCNH7 KCNH2

4.49e-0410602PF13426
DomainEGF_CA

EFEMP1 SLIT3 LRP2 LRP1B

6.37e-04122604SM00179
DomainTIL

MUC2 MUC5AC

6.56e-0412602PF01826
DomainC8

MUC2 MUC5AC

6.56e-0412602PF08742
DomainEGF-like_Ca-bd_dom

EFEMP1 SLIT3 LRP2 LRP1B

6.77e-04124604IPR001881
DomainEGF

SLIT3 LRP2 MUC4 LRP1B

7.19e-04126604PF00008
DomainUnchr_dom_Cys-rich

MUC2 MUC5AC

7.74e-0413602IPR014853
DomainC8

MUC2 MUC5AC

7.74e-0413602SM00832
DomainK_chnl_volt-dep_EAG/ELK/ERG

KCNH7 KCNH2

9.01e-0414602IPR003938
DomainLdl_recept_b

LRP2 LRP1B

9.01e-0414602PF00058
DomainLDLRB

LRP2 LRP1B

9.01e-0414602PS51120
DomainEGF

EFEMP1 SLIT3 LRP2 MUC4 LRP1B

9.40e-04235605SM00181
DomainEGF_extracell

LRP2 ADAM12 LRP1B

9.47e-0460603IPR013111
DomainEGF_2

LRP2 ADAM12 LRP1B

9.47e-0460603PF07974
DomainLY

LRP2 LRP1B

1.04e-0315602SM00135
DomainLDLR_classB_rpt

LRP2 LRP1B

1.04e-0315602IPR000033
DomainDisintegrin_CS

ADAM7 ADAM12

1.18e-0316602IPR018358
DomainADAM_CR

ADAM7 ADAM12

1.50e-0318602PF08516
DomainGrowth_fac_rcpt_

EFEMP1 SLIT3 LRP2 LRP1B

1.59e-03156604IPR009030
DomainVWC_out

MUC2 MUC5AC

1.68e-0319602SM00215
Domain-

ADAM7 ADAM12

1.86e-03206024.10.70.10
DomainDisintegrin

ADAM7 ADAM12

2.05e-0321602PF00200
DomainDISIN

ADAM7 ADAM12

2.05e-0321602SM00050
DomainPAS_fold_3

HIF1A KCNH7

2.46e-0323602IPR013655
DomainPAS_3

HIF1A KCNH7

2.46e-0323602PF08447
DomainEGF_CA

EFEMP1 LRP2 LRP1B

2.67e-0386603PF07645
DomainPAS

HIF1A KCNH2

2.90e-0325602PF00989
DomainPAS_fold

HIF1A KCNH2

2.90e-0325602IPR013767
DomainHECT

UBE3B HERC1

3.38e-0327602PF00632
DomainHECTc

UBE3B HERC1

3.38e-0327602SM00119
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC2 MUC4 MUC5AC

4.15e-0521463MM15706
Pubmed

Clinicopathological and prognostic significance of MUC-2, MUC-4 and MUC-5AC expression in japanese gastric carcinomas.

MUC2 MUC4 MUC5AC

5.13e-09361323464473
Pubmed

Polymorphism of human mucin genes in chest disease: possible significance of MUC2.

MUC2 MUC4 MUC5AC

5.12e-08561311062147
Pubmed

MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.

MUC2 MUC4 MUC5AC

5.12e-08561316475027
Pubmed

Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.

MUC2 MUC4 NOD2

5.12e-08561317058067
Pubmed

The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence.

PKHD1 LRP2 PKHD1L1

5.12e-08561320048263
Pubmed

Arf4 is required for Mammalian development but dispensable for ciliary assembly.

PKHD1 LRP2 PKHD1L1

1.79e-07761324586199
Pubmed

MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.

MUC4 MUC5AC

3.03e-06261218475301
Pubmed

IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma.

HIF1A MUC5AC

3.03e-06261229031476
Pubmed

Mucolytic activity of bacterial and human chitinases.

MUC2 MUC5AC

3.03e-06261217321686
Pubmed

Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.

MUC2 MUC5AC

3.03e-06261220731025
Pubmed

Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins.

MUC2 MUC5AC

3.03e-06261223832517
Pubmed

Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.

MUC2 MUC5AC

3.03e-06261223832516
Pubmed

Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice.

MUC4 MUC5AC

3.03e-06261219158956
Pubmed

Intestinal MUC2 and gastric M1/MUC5AC in preneoplastic lesions induced by 1,2-dimethylhydrazine in rat: a sequential analysis.

MUC2 MUC5AC

3.03e-06261217203232
Pubmed

Hypoxia induces mucin expression and secretion in human bronchial epithelial cells.

HIF1A MUC5AC

3.03e-06261223084780
Pubmed

Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.

MUC2 MUC5AC

3.03e-06261212527922
Pubmed

Ether-à-go-go-related gene K+ channels contribute to threshold excitability of mouse auditory brainstem neurons.

KCNH7 KCNH2

3.03e-06261219359372
Pubmed

Hypoxia-mediated mechanism of MUC5AC production in human nasal epithelia and its implication in rhinosinusitis.

HIF1A MUC5AC

3.03e-06261224840724
Pubmed

The nuclear kinesin KIF18B promotes 53BP1-mediated DNA double-strand break repair.

KIF18B TP53BP1

3.03e-06261234192545
Pubmed

Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1α via epidermal growth factor receptor-mediated signaling pathways.

HIF1A MUC5AC

3.03e-06261221544845
Pubmed

In vivo glycosylation of mucin tandem repeats.

MUC2 MUC5AC

3.03e-06261211445551
Pubmed

Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma.

MUC2 MUC5AC

3.03e-06261214594655
Pubmed

Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide.

MUC2 MUC5AC

3.03e-06261212820724
Pubmed

Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.

MUC2 MUC4 MUC5AC

4.11e-061861318834073
Pubmed

Detection of genes regulated by Lmx1b during limb dorsalization.

EFEMP1 LMX1B INSYN2B

8.87e-062361322417325
Pubmed

Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression.

MUC2 MUC4

9.07e-06361223305535
Pubmed

Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice.

MUC2 MUC4

9.07e-06361224714692
Pubmed

Identification of the cyclic-nucleotide-binding domain as a conserved determinant of ion-channel cell-surface localization.

KCNH7 KCNH2

9.07e-06361215961404
Pubmed

Differences in the expression of mucins in various forms of cystitis glandularis.

MUC2 MUC5AC

9.07e-06361217659847
Pubmed

Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

MUC2 MUC5AC

9.07e-06361218825309
Pubmed

Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.

MUC2 MUC5AC

9.07e-06361218300795
Pubmed

Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast.

MUC2 MUC5AC

9.07e-06361217333267
Pubmed

HERG K(+) currents in human prolactin-secreting adenoma cells.

KCNH7 KCNH2

9.07e-06361212634931
Pubmed

Mucin gene polymorphisms in otitis media patients.

MUC2 MUC5AC

9.07e-06361219718741
Pubmed

Developmentally regulated expression of the mouse homologues of the potassium channel encoding genes m-erg1, m-erg2 and m-erg3.

KCNH7 KCNH2

9.07e-06361214643686
Pubmed

ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.

HIF1A ITGA6

9.07e-06361227001172
Pubmed

Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells.

MUC2 MUC4

9.07e-06361220065027
Pubmed

Potassium Ion Channel Protein (KCNH) Levels in Patients with Fibromyalgia Syndrome.

KCNH7 KCNH2

9.07e-06361235818223
Pubmed

Gene expression profiling of colorectal mucinous adenocarcinomas.

MUC2 MUC5AC

9.07e-06361220485009
Pubmed

Fiber-deficient diet inhibits colitis through the regulation of the niche and metabolism of a gut pathobiont.

MUC2 NOD2

9.07e-06361237967555
Pubmed

Meconium ileus in cystic fibrosis is not linked to central repetitive region length variation in MUC1, MUC2, and MUC5AC.

MUC2 MUC5AC

9.07e-06361224920497
Pubmed

The role of the XBP-1/AGR2 signaling pathway in the regulation of airway Mucin5ac hypersecretion under hypoxia.

HIF1A MUC5AC

1.81e-05461231128106
Pubmed

Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M.

HIF1A OSMR

1.81e-05461231249305
Pubmed

Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.

MUC2 MUC5AC

1.81e-05461225638393
Pubmed

Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.

MUC2 MUC5AC

1.81e-05461222269464
Pubmed

Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.

MUC2 MUC5AC

1.81e-05461222691042
Pubmed

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries.

GIT2 NOD2

1.81e-05461237156999
Pubmed

Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells.

MUC2 MUC5AC

1.81e-05461212391274
Pubmed

Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.

MUC2 MUC5AC

1.81e-05461223807779
Pubmed

Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies.

MUC2 MUC4

1.81e-05461221647207
Pubmed

FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation.

FST ADAM12

1.81e-05461215574124
Pubmed

Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.

MUC2 MUC5AC

1.81e-05461233154304
Pubmed

Gastric mucin expression in first-degree relatives of gastric cancer patients.

MUC2 MUC5AC

1.81e-05461224901817
Pubmed

The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.

BMPR1A FST

1.81e-05461216198295
Pubmed

Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).

MUC2 MUC5AC

1.81e-05461236367122
Pubmed

Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.

MUC2 MUC5AC

1.81e-05461217471237
Pubmed

The mouse secreted gel-forming mucin gene cluster.

MUC2 MUC5AC

1.81e-05461214984930
Pubmed

HIF-1α, NOTCH1, ADAM12, and HB-EGF are overexpressed in mucoepidermoid carcinoma.

HIF1A ADAM12

1.81e-05461230415904
Pubmed

Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.

MUC2 MUC5AC

1.81e-05461229869461
Pubmed

[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].

MUC2 MUC5AC

1.81e-05461217991319
Pubmed

Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?

MUC2 MUC5AC

1.81e-05461220929551
Pubmed

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.

MUC2 MUC5AC

1.81e-05461227298226
Pubmed

PGE(2) induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activation.

MUC2 MUC5AC

1.81e-05461223619266
Pubmed

Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon.

MUC2 MUC4

1.81e-05461218198997
Pubmed

Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.

MUC2 MUC5AC

1.81e-05461217401217
Pubmed

Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.

MUC2 MUC5AC

1.81e-05461212676567
Pubmed

Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.

MUC2 MUC5AC

1.81e-05461225298197
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

LMX1B MYO9B KCNH2 UBE3B KAT6A AMBRA1 BTAF1 HERC1 ARHGEF11 NOD2

2.08e-051105611035748872
Pubmed

Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1.

ANLN LRP2

3.02e-05561217283184
Pubmed

Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.

MUC2 MUC5AC

3.02e-05561212507512
Pubmed

Association between genetic variants in myosin IXB and Crohn's disease.

MYO9B NOD2

3.02e-05561219235913
Pubmed

Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12.

MUC2 MUC5AC

3.02e-05561212135769
Pubmed

Differential expression of MUC genes in endometrial and cervical tissues and tumors.

MUC2 MUC5AC

3.02e-05561216188033
Pubmed

Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota.

MUC2 MUC4

3.02e-05561218035521
Pubmed

Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons.

BMPR1A FST

3.02e-05561211580864
Pubmed

pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins.

MUC2 MUC5AC

3.02e-05561210611155
Pubmed

Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?

MUC2 MUC5AC

3.02e-05561222261707
Pubmed

Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.

MUC2 MUC5AC

4.52e-05661219110483
Pubmed

Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum.

MUC2 MUC5AC

4.52e-05661216142311
Pubmed

Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins.

MUC2 MUC5AC

4.52e-05661217982272
Pubmed

Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.

BSN NOD2

4.52e-05661220024904
Pubmed

The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression.

HIF1A TP53BP1

4.52e-05661217024177
Pubmed

FOXL2 and BMP2 act cooperatively to regulate follistatin gene expression during ovarian development.

BMPR1A FST

4.52e-05661221084449
Pubmed

Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.

GIPR HIF1A

4.52e-05661225537494
Pubmed

The TIP60 Complex Is a Conserved Coactivator of HIF1A.

HIF1A MYO9B BTAF1 XPOT

6.04e-0512061427320910
Pubmed

Glucose metabolism induced by Bmp signaling is essential for murine skeletal development.

BMPR1A HIF1A

8.42e-05861230446646
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

RLF ANLN KAT6A BTAF1 KIF18B PRDM15 ZMYM4

9.29e-0560861736089195
Pubmed

DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins.

BMPR1A FST

1.08e-04961220860622
Pubmed

Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate.

KCNH7 KCNH2

1.35e-041061226503718
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

BMPR1A SLC16A1 KAT6A SCAPER LRP2 AMBRA1 OSMR KIF18B ZNF574

1.35e-04111661931753913
Pubmed

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.

GIPR LMX1B LRP1B

1.48e-045861320935630
Pubmed

Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.

THSD4 PRG3 EFEMP1 MUC2

1.55e-0415361425037231
Pubmed

Ablation of cholesterol biosynthesis in neural stem cells increases their VEGF expression and angiogenesis but causes neuron apoptosis.

HIF1A LRP2

1.65e-041161219416849
Pubmed

LRP2 mediates folate uptake in the developing neural tube.

LRP2 LRP1B

1.65e-041161224639464
Pubmed

Convergence of bone morphogenetic protein and laminin-1 signaling pathways promotes proliferation and colony formation by fetal mouse pancreatic cells.

BMPR1A ITGA6

1.97e-041261215913604
Pubmed

Association of genetic profiles to Crohn's disease by linear combinations of single nucleotide polymorphisms.

MYO9B NOD2

1.97e-041261218804983
Pubmed

BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb.

BMPR1A LMX1B

1.97e-041261211714671
Pubmed

Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.

BSN TP53BP1

1.97e-041261228700933
Pubmed

Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.

HIF1A KAT6A LRP2 ARHGEF11 NOD2

2.25e-0431361520800603
Pubmed

Conditional stabilization of beta-catenin expands the pool of lung stem cells.

MUC2 MUC5AC

2.33e-041361218356571
Cytoband2q21.2

LYPD1 LRP1B

1.56e-04146122q21.2
GeneFamilyCD molecules|Mucins

MUC2 MUC4 MUC5AC

1.73e-0521443648
GeneFamilyLow density lipoprotein receptors

LRP2 LRP1B

4.44e-0413442634
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

RLF ZBTB49 ZNF492 ZNF781 SCAPER PRDM15 ZNF574

1.61e-0371844728
GeneFamilyADAM metallopeptidase domain containing|CD molecules

ADAM7 ADAM12

1.95e-032744247
GeneFamilyPotassium voltage-gated channels

KCNH7 KCNH2

4.26e-0340442274
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

RLF BMPR1A HIF1A MYO9B KAT6A USP12 ITGA6 BTAF1 OSMR CAMSAP2 ZMYM4 TP53BP1

5.45e-078566112M4500
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000

RLF EXOC5 HIF1A ITGA6 INSYN2B HERC1 FST

4.61e-06233617gudmap_developingGonad_e12.5_ovary_k5_1000
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000

SCAPER ITGA6 PHF7 INSYN2B HERC1 FST

8.69e-06168616gudmap_developingGonad_P2_ovary_1000_k4
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000

SCAPER ITGA6 PHF7 INSYN2B HERC1 FST

1.25e-05179616gudmap_developingGonad_e14.5_ ovary_1000_k5
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51AP2 GIPR HERC1 BSN MUC4 XPOT

1.43e-07174616f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCellCOVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type

DLGAP1 LYPD1 SLIT3 PKHD1 LRP2

3.44e-06168615a086c306be430adf0632ba53e98cd8014d2de330
ToppCellP28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

EFEMP1 SLC16A1 SLITRK4 LRP2 PKHD1L1

4.56e-061786151e05bc26591fea16e29bcfc5f538dda1dc427f05
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 EFEMP1 SLITRK4 LRP2 PKHD1L1

4.56e-06178615bcbdd45a2307f8aea14122fa0144b96b1f6eec48
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 EFEMP1 SLITRK4 LRP2 PKHD1L1

4.56e-06178615c413861148129be1ee94f2ceb5999840217eebe5
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51AP2 GIPR HERC1 BSN MUC4

4.56e-06178615fcbbcc44271515de1969b4732b6441c012693d5f
ToppCellE17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

THSD4 EFEMP1 SLITRK4 LRP1B PKHD1L1

5.35e-06184615607b55022de21ddb6a2d75e085df76df7abf6624
ToppCellCOPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

EFEMP1 SLC16A1 SLIT3 OSMR PKHD1L1

5.50e-0618561523579988036fc1925992c31919750f9b3fe9f790
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 SLIT3 LRP2 FST PKHD1L1

5.79e-061876154e553721fa5598cb211f44e3226280b7e6885484
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 SLIT3 LRP2 FST PKHD1L1

5.79e-06187615d36e7fc6125e7a4310499365022d38f34b757a73
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 SLIT3 LRP2 FST PKHD1L1

5.79e-06187615827eae63fabf6892a82ce7779b5f395958d3d628
ToppCellCOPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class

EFEMP1 SLC16A1 SLIT3 OSMR PKHD1L1

6.10e-0618961579bb2593ad5d17f94b17972884241f03a0f43770
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EFEMP1 SLC16A1 SLIT3 LRP2 PKHD1L1

6.42e-061916155343a527de6b0f852f45020a91f5b4869e78f13a
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EFEMP1 SLC16A1 SLIT3 LRP2 PKHD1L1

6.42e-06191615a25a5f9a380031fdaf57677a079f97a90f0550c0
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

EFEMP1 SLIT3 OSMR FST LRP1B

7.46e-061976153bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

EFEMP1 SLIT3 OSMR FST LRP1B

7.46e-0619761517344464fdcc5ba0c03959696b97c195f11e644c
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

EFEMP1 SLIT3 OSMR FST LRP1B

7.46e-061976155b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

EFEMP1 SLC16A1 SLIT3 FST PKHD1L1

8.02e-06200615c800f20adedf4ca736c740510889e92d8bf0ba44
ToppCellParenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

EFEMP1 SLC16A1 SLIT3 FST PKHD1L1

8.02e-06200615bf50e30d5cafb71c567e89580f62084d2f894170
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

EFEMP1 SLC16A1 SLIT3 FST PKHD1L1

8.02e-062006155e5ad07679d5dd2ca80249bce9aaf4a95d42187b
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9

KCNH2 LRP2 BSN MUC2

5.21e-05149614649eb3441fa859591ea85f1ed5fcf08af272a32b
ToppCellPosterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

THSD4 EFEMP1 LMX1B PKHD1

5.77e-05153614151c469b26f9adf04dd6f117f03bef760cc3d45d
ToppCellfacs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INSYN2B FST ADAM12 XPOT

6.54e-0515861412661763d1c309106801cb710c04cd2b62d16cba
ToppCellfacs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INSYN2B FST ADAM12 XPOT

6.54e-05158614e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72
ToppCellfacs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INSYN2B FST ADAM12 XPOT

6.54e-051586140792c39e6fc0745095af7812de2d50949540d60f
ToppCellFetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

GIPR LYPD1 KCNH7 BSN

6.70e-051596147747cef94c55144fddcd024a7495318357f1351b
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PKHD1 LRP2 LRP1B PKHD1L1

6.86e-05160614c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PKHD1 LRP2 LRP1B PKHD1L1

6.86e-0516061425c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANLN SLIT3 KIF18B ADAM12

7.03e-05161614a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANLN SLIT3 KIF18B ADAM12

7.03e-0516161408920a716f6ec62538e361211455a30ad726d7be
ToppCellfacs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAM7 PKHD1 LRP1B PKHD1L1

7.20e-05162614bf886e22ff2a20353499004b53f25fb9e6574896
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9

HIF1A ADAM12 MUC2 MUC5AC

7.55e-051646143c15e9b8403b03d67f6ecd7861dc19f1261e3244
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

RAD51AP2 SLIT3 FST MUC5AC

7.73e-051656148a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCellControl-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

EFEMP1 SLIT3 FST PKHD1L1

7.92e-0516661432ebaefa6c074b28193fff764ee7c2c0e9357e20
ToppCellP15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

EFEMP1 SLC16A1 SLITRK4 PKHD1L1

7.92e-05166614545f6c91102568791443717e522f89cb3bd1a070
ToppCellmoderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

BMPR1A KCNH2 ADAM12 LRP1B

7.92e-05166614c3835b424c63bf11a4e2c47635dc3787fc4a637a
ToppCellControl-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class

EFEMP1 SLIT3 FST PKHD1L1

7.92e-051666141ed3788257e14f097862b999f020bfe2a57de52b
ToppCellPND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EFEMP1 SLC16A1 LRP2 PKHD1L1

8.10e-05167614c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 EFEMP1 SLC16A1 PKHD1L1

8.10e-051676147abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 EFEMP1 SLC16A1 PKHD1L1

8.10e-05167614d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCellPND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EFEMP1 SLC16A1 LRP2 PKHD1L1

8.10e-05167614351f8de1fbdf742ac74f9099b254d515ab539bb2
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PKHD1 LRP2 LRP1B PKHD1L1

8.48e-0516961412bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

THSD4 SLIT3 SLITRK4 FST

8.88e-051716144ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HIF1A MYO9B SLITRK4 NOD2

8.88e-051716145e93c76ee60f9d0590ebb140812653a5e1369417
ToppCell11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class

EFEMP1 MUC2 MUC4 MUC5AC

9.08e-051726149d4d92e2d16dfc8a394f2641653bb97de20a2530
ToppCellP07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

EFEMP1 SLC16A1 SLITRK4 PKHD1L1

9.08e-051726149a256db817c1af1802203cc88a55d608fb328c63
ToppCellCOVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type

DLGAP1 LYPD1 SLIT3 LRP2

9.08e-0517261436a96714a0eb6ac438648135336c9791881ddadb
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EFEMP1 SLC16A1 SLITRK4 PKHD1L1

9.29e-05173614ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCellwk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

THSD4 ZNF492 SLITRK4 LRP1B

9.29e-05173614b43817a6b1ed8d6b5366702343be4311c0d52d83
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EFEMP1 SLC16A1 SLITRK4 PKHD1L1

9.29e-051736143725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 EFEMP1 SLC16A1 PKHD1L1

9.29e-0517361430d67738633493d47f06ae452424382f069b6c0a
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

RAD51AP2 SLIT3 FST MUC5AC

9.29e-051736145416b092321c7d9b63f0418c60f2402a138355bf
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 EFEMP1 SLC16A1 PKHD1L1

9.50e-05174614a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCellCOVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

PKHD1 LRP2 CRPPA LRP1B

9.92e-0517661436f77d878a53b30465b0dea8333a3865dba75613
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LYPD1 ANLN KIF18B FST

1.01e-041776143e149bff1f1b393a7abe98984e37981c8296f95d
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

EFEMP1 SLC16A1 FST PKHD1L1

1.01e-041776140912a291cff32a4ff8a2d7680ed1a1cd867fb90f
ToppCellPCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

LYPD1 LRP2 ITGA6 ADAM12

1.01e-0417761459726bfd98f656fdcedf448a7e2e76a9bfad8285
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 EFEMP1 LRP2 PKHD1L1

1.04e-04178614a107dd98a07086ed0429116095ecda60c9dbef1e
ToppCellCOVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

DLGAP1 SLIT3 PKHD1 LRP2

1.04e-04178614544379f5a6145429762258d426b876bb36c112f5
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EFEMP1 SLIT3 LRP2 PKHD1L1

1.06e-04179614056df2aaff750e0e283e7da78fcc3c90c366aac0
ToppCelldroplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLITRK4 LRP2 MUC4 PKHD1L1

1.06e-041796144135f9e8cd8494cbc189e5210dded84659643fb8
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EFEMP1 SLIT3 LRP2 PKHD1L1

1.06e-04179614f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11
ToppCellIPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class

EFEMP1 SLC16A1 SLIT3 PKHD1L1

1.08e-041806141fa54bf4dba72866b2295639d991af639341bc08
ToppCellP03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

EFEMP1 SLC16A1 SLITRK4 PKHD1L1

1.08e-041806142ccc77d769d3ffd77ab3af45e4f192785b6db79c
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EFEMP1 SLC16A1 LRP2 PKHD1L1

1.11e-04181614330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

THSD4 EFEMP1 OSMR MUC4

1.11e-04181614576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

SLC16A1 KCNH2 FST ADAM12

1.11e-04181614ef579e958f334da0f9415aa7e3d5c02c807954a6
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

EFEMP1 SLC16A1 LRP2 PKHD1L1

1.11e-041816143f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EFEMP1 LRP2 PKHD1L1 MUC5AC

1.15e-041836149d5a363fbe6f0a1668c9d584df65ee1c283349c7
ToppCellIPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class

EFEMP1 SLC16A1 SLIT3 PKHD1L1

1.15e-041836147df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EFEMP1 LRP2 PKHD1L1 MUC5AC

1.15e-04183614c5caac6ed6c8d67f5c336281d9fd903976509445
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THSD4 EFEMP1 SLITRK4 PKHD1L1

1.15e-04183614ebe369dc80c4fbf8f4dbe947147f8c47507ffb60
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PKHD1 LRP2 LRP1B PKHD1L1

1.18e-041846142cbed6462fea2622871bb7e49b0df3d984239281
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP1 OSMR ADAM12 LRP1B

1.18e-04184614d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PKHD1 LRP2 LRP1B PKHD1L1

1.18e-04184614ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PKHD1 LRP2 LRP1B PKHD1L1

1.18e-041846142b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellControl-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class

SLC16A1 SLIT3 FST PKHD1L1

1.20e-041856140af540323c0113203ba6c1a4cb32d2fb9cf79d39
ToppCelldroplet-Tongue-nan-24m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 ITGA6 OSMR FST

1.25e-0418761413056622d9921ee0b03325701d94df82ffbaa5d4
ToppCellCOVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type

THSD4 SLIT3 OSMR ADAM12

1.25e-0418761476bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

RLF BTAF1 HERC1 TP53BP1

1.28e-04188614ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellCOPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class

HIF1A SLC16A1 SLIT3 PKHD1L1

1.28e-04188614159d63ecc3653a7449fc6acefd6ef0464845260e
ToppCelldroplet-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 ANLN OSMR NOD2

1.31e-04189614258ef4a52f90236dbed92f325ca033c8fa6156a5
ToppCellSevere_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30)

OSMR MUC4 PKHD1L1 MUC5AC

1.31e-041896148cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCellfacs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 SLIT3 OSMR FST

1.33e-04190614990ac07f4b0a22041daac7502f74fafd6d258cba
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 DLGAP1 SLIT3 ADAM12

1.33e-041906142306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 DLGAP1 SLIT3 ADAM12

1.33e-041906141f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCellfacs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 SLIT3 OSMR FST

1.33e-04190614fc9bbe5e6e0ec3cfa47bf479d8b09a0fc53169cc
ToppCellfacs-Thymus-Flowthrough-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 SLIT3 OSMR FST

1.33e-0419061439ecdf8815e235771132684dfc1aff1917e20965
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 DLGAP1 SLIT3 ADAM12

1.36e-04191614a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

THSD4 DLGAP1 SLIT3 CRPPA

1.36e-0419161414057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 DLGAP1 SLIT3 ADAM12

1.39e-041926149093a9e94a25682d109a7f6edc256a25a61103a0
ToppCellPCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

PKHD1 LRP2 ITGA6 KIF18B

1.39e-0419261425378b5e4b0cea8415ff125783511fc25a56fc00
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 DLGAP1 SLIT3 ADAM12

1.39e-041926149ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EFEMP1 SLIT3 OSMR FST

1.39e-04192614fc940f91ff8e051631dbf25e6e8d73cf8337eccb
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EFEMP1 SLIT3 OSMR FST

1.39e-041926147a2e79490e4f7058bb76b46c45b5df9f729e3146
ToppCellPCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LMX1B PKHD1 LRP2 MUC5AC

1.39e-04192614b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCellfacs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EFEMP1 SLIT3 OSMR FST

1.39e-04192614e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba
ToppCelldroplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 SLIT3 FST ADAM12

1.41e-04193614316ebdf15f75d88c348f909b643fcd315364ca84
ToppCelldroplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFEMP1 SLIT3 FST ADAM12

1.41e-041936141afdd3f7d703f4204a2cbfe40e135ac7b09213f7
ToppCellsevere-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

GIPR SCAPER BTAF1 HERC1

1.41e-041936149337bc93e3904c7fc7c93c328518bcd6453b1e8c
DrugGallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A

GIPR KCNH2 KAT6A PHF7 ADAM12 MUC4 MUC5AC

9.27e-071966172221_UP
DrugFlurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A

GIPR ADAM7 LRP2 PHF7 FST MUC4

1.37e-051956166039_UP
DrugStrophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A

EXOC5 LYPD1 MYO9B KCNH2 UBE3B ITGA6

1.41e-051966167182_UP
DrugRitodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; MCF7; HT_HG-U133A

EXOC5 ITGA6 AMBRA1 GIT2 ARHGEF11 ZNF574

1.45e-051976162635_DN
DrugFluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A

KCNH2 KAT6A SCAPER LRP2 FST ADAM12

1.54e-051996163839_UP
DrugOvalbumin

HIF1A LRP2 MUC2 MUC5AC

6.98e-0582614ctd:D010047
DrugDoxazosin

KCNH7 KCNH2

1.05e-046612DB00590
DrugPrazosin

KCNH7 KCNH2

1.05e-046612DB00457
DrugTerazosin

KCNH7 KCNH2

1.05e-046612DB01162
DrugDoxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A

EXOC5 LYPD1 SCAPER GIT2 OSMR

1.60e-041916157195_UP
DrugClotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A

RLF LYPD1 SLC16A1 GIT2 ARHGEF11

1.64e-041926156207_DN
DrugGlycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A

LMX1B GIT2 OSMR FST MUC5AC

1.72e-041946154709_UP
DrugRiluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A

LYPD1 MYO9B UBE3B GIT2 OSMR

1.72e-041946152295_DN
DrugCinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A

THSD4 MYO9B KAT6A LRP2 FST

1.72e-041946152789_UP
Drug15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A

EXOC5 EFEMP1 UBE3B OSMR MUC2

1.72e-041946157494_UP
Drug11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A

EXOC5 KAT6A ITGA6 GIT2 OSMR

1.72e-041946157538_DN
DrugButylparaben [94-26-8]; Up 200; 20.6uM; PC3; HT_HG-U133A

ADAM7 PHF7 MUC2 MUC4 NOD2

1.77e-041956154647_UP
DrugButylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A

MYO9B KCNH2 UBE3B ARHGEF11 ZMYM4

1.77e-041956155245_DN
DrugTestosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A

SLC16A1 MYO9B KCNH2 AMBRA1 GIT2

1.77e-041956152649_DN
DrugOxolinic acid [14698-29-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A

KAT6A SCAPER ITGA6 AMBRA1 GIT2

1.81e-041966155519_DN
DrugNialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A

KAT6A GIT2 OSMR ARHGEF11 ZNF574

1.81e-041966154347_DN
DrugEstriol [50-27-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A

DLGAP1 PHF7 OSMR ARHGEF11 MUC5AC

1.81e-041966153563_UP
DrugCyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; PC3; HT_HG-U133A

SCAPER LRP2 AMBRA1 PHF7 GIT2

1.81e-041966155734_DN
DrugGabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A

LYPD1 KCNH2 UBE3B OSMR ZMYM4

1.81e-041966157357_DN
DrugDydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A

LYPD1 MYO9B KCNH2 SCAPER AMBRA1

1.81e-041966152811_DN
DrugTerconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A

GIPR PHF7 MUC2 MUC4 NOD2

1.81e-041966154407_UP
DrugBromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A

THSD4 MYO9B ADAM7 FST ADAM12

1.85e-041976153617_UP
DrugFipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; MCF7; HT_HG-U133A

MYO9B KCNH2 ITGA6 GIT2 ARHGEF11

1.85e-041976153176_DN
DrugLovastatin [75330-75-5]; Down 200; 9.8uM; HL60; HT_HG-U133A

LRP2 PHF7 ARHGEF11 CAMSAP2 NOD2

1.85e-041976152494_DN
Drug6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A

LMX1B KAT6A GIT2 ADAM12 NOD2

1.85e-041976156813_UP
DrugMeprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A

EFEMP1 MYO9B UBE3B SCAPER ARHGEF11

1.85e-041976156204_UP
DrugPralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A

EXOC5 ITGA6 GIT2 ARHGEF11 ZNF574

1.85e-041976156443_DN
DrugMeropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A

LYPD1 MYO9B SCAPER ITGA6 OSMR

1.85e-041976157180_UP
DrugLorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A

KAT6A LRP2 PHF7 MUC2 MUC5AC

1.85e-041976154658_UP
DrugNadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A

PRG3 LMX1B KCNH2 SCAPER MUC4

1.85e-041976156091_UP
DrugCholecalciferol [67-97-0]; Up 200; 10.4uM; HL60; HT_HG-U133A

LRP2 ADAM12 CAMSAP2 MUC4 NOD2

1.90e-041986152436_UP
DrugAtractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A

THSD4 LMX1B SCAPER GIT2 ARHGEF11

1.90e-041986154717_UP
DrugNaltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A

EXOC5 ITGA6 GIT2 OSMR ZMYM4

1.90e-041986156241_DN
DrugGlafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; PC3; HT_HG-U133A

MYO9B KAT6A AMBRA1 GIT2 ARHGEF11

1.90e-041986157257_UP
DrugMetyrapone [54-36-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A

SCAPER LRP2 OSMR MUC4 NOD2

1.90e-041986156447_UP
DrugOxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A

MYO9B LRP2 GIT2 OSMR ZNF574

1.94e-041996153344_DN
DrugMafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A

GIPR SCAPER LRP2 PHF7 MUC5AC

1.94e-041996155079_UP
Drugrosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A

LYPD1 MYO9B SCAPER ITGA6 ARHGEF11

1.94e-041996156950_DN
Drugestradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A

EFEMP1 SLC16A1 ITGA6 GIT2 ZNF574

1.94e-041996156968_DN
DrugChenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A

THSD4 LMX1B MYO9B PHF7 ADAM12

1.94e-041996156012_UP
DrugMethantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A

SLC16A1 ADAM7 SCAPER ADAM12 MUC5AC

1.94e-041996153560_UP
Drug4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid

MUC2 MUC5AC

1.96e-048612ctd:C064545
DrugMiconazole

KCNH7 KCNH2

1.96e-048612DB01110
Drugchlorpropamide; Down 200; 100uM; MCF7; HG-U133A

SLIT3 USP12 FST ADAM12 ZMYM4

1.99e-04200615141_DN
DrugFlucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A

LMX1B SCAPER LRP2 FST NOD2

1.99e-042006156450_UP
DrugTrimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A

THSD4 GIPR EXOC5 KCNH2 MUC5AC

1.99e-042006154787_UP
Druglinopirdine

KCNH7 KCNH2 BSN

2.09e-0443613CID000003932
Diseasemucinous adenocarcinoma (is_marker_for)

MUC2 MUC4 MUC5AC

7.57e-085593DOID:3030 (is_marker_for)
Diseasecystitis (is_marker_for)

MUC2 MUC5AC

3.93e-062592DOID:1679 (is_marker_for)
Diseasesputum mucin-5B amount

MUC2 MUC5AC

1.18e-053592OBA_2050332
Diseaseintestinal disease (is_implicated_in)

BMPR1A NOD2

1.18e-053592DOID:5295 (is_implicated_in)
Diseaseepilepsy (implicated_via_orthology)

KCNH7 KCNH2 ITGA6 BSN LRP1B

1.90e-05163595DOID:1826 (implicated_via_orthology)
Diseasemucositis (biomarker_via_orthology)

MUC2 MUC4

3.92e-055592DOID:0080178 (biomarker_via_orthology)
Diseasedisease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement

THSD4 ADAM12 LRP1B

3.97e-0533593EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090
DiseaseSchizophrenia

DLGAP1 LMX1B MYO9B KCNH2 SLIT3 LRP2 AMBRA1 ARHGEF11 ADAM12

6.07e-05883599C0036341
Diseasefat body mass

THSD4 DLGAP1 KCNH7 LMX1B CRPPA

7.45e-05217595EFO_0005409
DiseaseStage IV Skin Melanoma

ADAM7 ADAM12

8.20e-057592C1321872
Diseasebiliary tract benign neoplasm (is_marker_for)

MUC4 MUC5AC

8.20e-057592DOID:0050625 (is_marker_for)
Diseasecommon bile duct neoplasm (is_marker_for)

MUC4 MUC5AC

1.09e-048592DOID:4608 (is_marker_for)
Diseasehealth-related quality of life measurement

EXOC5 LMX1B

1.40e-049592EFO_0011014
Diseasebringing up phlegm, sputum or mucus on most days, self-reported

MUC2 MUC5AC

1.40e-049592EFO_0009824
DiseaseFocal segmental glomerulosclerosis

LMX1B ANLN

1.75e-0410592cv:C0017668
DiseaseInherited focal segmental glomerulosclerosis

LMX1B ANLN

1.75e-0410592cv:CN327126
Diseaseallergic conjunctivitis (is_marker_for)

MUC2 MUC4

1.75e-0410592DOID:11204 (is_marker_for)
Diseaselong QT syndrome (implicated_via_orthology)

KCNH7 KCNH2

1.75e-0410592DOID:2843 (implicated_via_orthology)
DiseaseHereditary Nephrotic Syndromes, Autosomal Dominant

LMX1B ANLN

2.14e-0411592cv:CN043612
Diseaseendometrial neoplasm

ADAM12 ZMYM4

2.14e-0411592EFO_0004230
Diseasefollistatin measurement

FST TP53BP1

2.14e-0411592EFO_0010614
DiseaseAbruptio Placentae

INSYN2B ADAM12

2.56e-0412592EFO_1001754
Diseaseglaucoma

EFEMP1 LMX1B PKHD1 LRP1B

2.60e-04154594MONDO_0005041
DiseaseNon-Small Cell Lung Carcinoma

GIPR HIF1A OSMR TP53BP1

2.73e-04156594C0007131
Diseasecholangiocarcinoma (is_marker_for)

MUC2 MUC4 MUC5AC

2.90e-0464593DOID:4947 (is_marker_for)
DiseaseFamilial idiopathic steroid-resistant nephrotic syndrome

LMX1B ANLN

3.02e-0413592cv:C4273714
Diseasekeratoconus

PKHD1 FST LRP1B

3.18e-0466593MONDO_0015486
Diseaselysophosphatidylcholine 15:0 measurement

PKHD1 LRP1B

3.52e-0414592EFO_0020941
Diseasesusceptibility to childhood ear infection measurement

EFEMP1 CRPPA BSN ADAM12

3.87e-04171594EFO_0007904
Diseaseunipolar depression, bipolar disorder, schizophrenia, sex interaction measurement

THSD4 ADAM12 LRP1B

4.81e-0476593EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090
DiseaseEye Abnormalities

BMPR1A CRPPA

5.24e-0417592C0015393
Diseaseotitis media (biomarker_via_orthology)

MUC4 MUC5AC

5.24e-0417592DOID:10754 (biomarker_via_orthology)
DiseaseFebrile seizure (within the age range of 3 months to 6 years)

HERC1 BSN

5.89e-0418592HP_0002373
DiseaseFEV/FEC ratio

THSD4 EFEMP1 ZNF781 LMX1B SCAPER CRPPA HERC1 FST ADAM12

7.01e-041228599EFO_0004713
Diseaseinfluenza A (H1N1)

SLITRK4 ADAM12 LRP1B

7.14e-0487593EFO_1001488
DiseaseS-warfarin measurement

ADAM7 ADAM12 LRP1B

9.80e-0497593EFO_0803323
Diseaseocular sarcoidosis

KCNH7 LRP2 AMBRA1

1.64e-03116593EFO_0010723
Diseasesleep quality

DTD1 MYO9B LRP1B

1.72e-03118593EFO_0005272
Diseasebody surface area

GIPR EFEMP1 MYO9B KCNH2 SLIT3 PKHD1

1.77e-03643596EFO_0022196
Diseaseheart conduction disease (implicated_via_orthology)

KCNH7 KCNH2

1.88e-0332592DOID:10273 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
KVYISTNCPSQCNEN

ADAM7

626

Q9H2U9
QQVAAQFCSYQSIAL

ARHGEF11

826

O15085
CYNGICQTHEQQCVT

ADAM12

521

O43184
SESCQQERSCQYLQV

DLGAP1

306

O14490
CRTAQIVTQYCVGAN

GIPR

216

P48546
TDVQLVTQQVIQCAY

GIT2

726

Q14161
NVLVQNCKIYNDASC

AMBRA1

881

Q9C0C7
ISSNYCNCSSIQCNV

RAD51AP2

346

Q09MP3
ICYVSRNIQNNVSCY

OSMR

166

Q99650
ILDQCYNFVCVNVTT

CRPPA

331

A4D126
IAASFCNTVQQLYVC

SLC16A1

101

P53985
CNAESQCLYNQTSRV

MUC4

5036

Q99102
LLSNCQQLNCQYKCT

LRP1B

116

Q9NZR2
LQFQVTNYCVRVCAT

KIAA0825

591

Q8IV33
IANARVQNCAIIYCN

KCNH7

31

Q9NS40
NTKNSQPQCIVCVNY

HIF1A

326

Q16665
QTVIYQASQALNCCV

ANLN

731

Q9NQW6
QVICGQNCTFVIQAN

HERC1

4031

Q15751
IANARVENCAVIYCN

KCNH2

31

Q12809
NYNTCTTCRLQVCNL

BSN

481

Q9UPA5
CASLQAYAALCAQQN

MUC2

4731

Q02817
GCLYQTCQQNQFTCQ

LRP2

3026

P98164
NYEIRIQCCETVNVC

MUC5AC

2036

P98088
SSTCVVDQTNNAYCV

FST

176

P19883
VDQTNNAYCVTCNRI

FST

181

P19883
KYQTLNCSVNVNCVN

ITGA6

961

P23229
ISQYATICQQLQAEV

KIF18B

366

Q86Y91
YRIQCCTSTVNQAQV

PRG3

146

Q9Y2Y8
VDGNVSTIYCQNLCL

KAT6A

581

Q92794
QYEILCVSQFTLQCV

DTD1

71

Q8TEA8
NNVLIQYTNACVKVC

EXOC5

566

O00471
YAAQCIAKLLQQCTT

BTAF1

896

O14981
TIECCRTNLCNQYLQ

BMPR1A

121

P36894
LQIQCYQCEEFQLNN

LYPD1

21

Q8N2G4
SLCNAINVYNLTCNN

SCAPER

986

Q9BY12
INVYNLTCNNCSENC

SCAPER

991

Q9BY12
NTTLNVYLCQSENSC

PKD1L1

376

Q8TDX9
QLIQEFCQEYLNQCC

CAMSAP2

291

Q08AD1
VYQCNSLEQAQAICK

ITGB1BP1

171

O14713
QQCYNILGSFICQCN

EFEMP1

266

Q12805
ICNVCSCVSVENVLY

SLITRK4

26

Q8IW52
SVENIQSPCCSQAIY

PHF7

171

Q9BWX1
RVYQCNICSKIFQNS

PRDM15

736

P57071
CKVIFSNQTNVVCQT

PKHD1

971

P08F94
YECQNGAQCIVVQQE

SLIT3

1126

O75094
CCYVFSAQQLQAAQV

NOD2

561

Q9HC29
NVSSFQQAYITCLCS

RLF

246

Q13129
VCQSETCQRYLQAAI

SPATA12

76

Q7Z6I5
VQESQYQCLECGQLL

ZNF574

71

Q6ZN55
LVNFGNTCYCNSVLQ

USP12

41

O75317
FNEAQCNTAYQCLLI

TP53BP1

1791

Q12888
VVINFQAYCCILQDC

PKHD1L1

2996

Q86WI1
ECYNGLNQCLTTTQN

ZNF492

96

Q9P255
EVQKVCNICVLYQTS

UBE3B

456

Q7Z3V4
LQNYQFTNSEVTCQC

XPOT

191

O43592
YCKLCNVTLNSAQQA

ZMAT3

71

Q9HA38
SQTLQSQRQYACELC

ZBTB49

386

Q6ZSB9
NCNVVVQARLCVYNY

THSD4

981

Q6ZMP0
VAETACNFQLTQYQI

ZNF781

11

Q8N8C0
QVQCNSCKTSAIPQY

ZMYM4

576

Q5VZL5
NCSTCQNTACIIYSV

INSYN2B

461

A6NMK8
LQCAACQQALTTSCY

LMX1B

81

O60663
ASYQVSIPQSCEQCL

MYO9B

1636

Q13459